Marketing innovation: Medical device prices follow the experience curve

Journal of Medical Marketing

Volumn 7, Issue 3, 2007, Pages 203-212

  Brown, Alan ^a   Meenan, Brian J ^a   Young, Terry P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250378687     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/palgrave.jmm.5050086     Document Type: Article

References (22)

1. NHS National Institute for Clinical Excellence (2004). Guide to the methods of technology appraisal. Available from http://www.nice.org.uk/ download.aspx?o=201973.
2. Wright, T. P. (1935). Factors affecting the cost of airplanes. J. Aeronaut. Sci. 3, 275-282.
3. Alchian, A. (1963). Reliability of progress curves in airframe production. Econometrica 31(4), 679-693.
4. Henderson, B. D. (1974). The experience curve - reviewed I. Concept 124, 1-2.
5. Henderson, B. D. (1974). The experience curve - reviewed V. Price Stabil 149, 1-3.
6. Henderson, B. D. (1984). The application and misapplication of the experience curve. J. Bus. Strat. 4(3), 3-9.
7. Lieberman, M. B. (1984). The learning curve and pricing in the chemical processing industries. Rand J. Econ. 15(2), 213-228.
8. Zimmerman, M. B. (1982). Learning effects and the commercialization of new energy technologies: The case of nuclear power. Bell J. Econ. 13(2), 297-310.
9. Gelijns, A. & Rosenberg, N. (1994). The dynamics of technological change in medicine. Health Aff. 13(3), 28-46.
10. Bodenheimer, T. (2005). High and rising health care costs. Part 2: technologic innovation. Ann. Intern. Med. 142(11), 932-937.
11. Lubitz, J. (2005). Health, technology and medical care spending. Health Affairs 24, 81-86.
12. Rettig, R. A. (1994). Medical innovation duels cost containment. Health Affairs 13(3), 7-27.
13. Newhouse, J. P. (1992). Medical care costs: How much welfare loss? J. Econ. Perspect. 6(3), 3-21.
14. Parmenter, E. M. (2004). Health care benefit crisis: Cost drivers and strategic solutions. J. Financ. Serv. Professionals 58(4), 63-78.
15. Neumann, P. J., Rosen, A. B. & Weinstein, M. C. (2005). Medicare and cost-effectiveness analysis. N. Engl. J. Med. 353(14), 1516-1522.
16. Cohen, B. (2006) Drug eluting stents. www.Angioplasty.org. http://www.ptca.org/articles/des.html. Accessed 23rd August, 2006.
17. Boston Scientific Inc. (2006). Drug-eluting stenting, Boston Scientific Inc. Available at: http://www.bostonscientific.com/patient_ed/ PEprocedureOverview.jsp?task=tskPEprocedureOverview.jsp§ionId= 3&relId=1001,1016. Accessed 23rd August, 2006.
18. Cordis Corporation (2006). Cypher: How does it work?, Cordis Corporation. http://www.cypherusa.com/cypher-j2ee/cypherjsp/about/ how_does_it_work.jsp. Accessed 23rd August, 2006.
19. Inflationdata.com (2006) Historical CPI-U data from 1913 to the present Inflationdata.com http://inflationdata.com/Inflation/ Consumer_Price_Index/HistoricalCPI.aspx. Accessed 21st August, 2006.
20. Office of National Statistics (2006). Consumer Prices Index (CPI), Office of National Statistics. http://www.statistics.gov.uk/STATBASE/ tsdataset.asp?vlnk=7174&More=N&All=Y. Accessed 21st August, 2006.
21. Buxton, A. E. (2003). The clinical use of implantable cardioverter defibrillators: Where are we now? Where should we go? Ann. Intern. Med. 138(6), 512-514.
22. Buxton, M., Caine, N., Chase, D., Connelly, D., Grace, A., Jackson, C., Parkes, J. & Sharples, L. (2006). A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and the modelling of cost-effectiveness and cost-utility for these groups in a UK context, 10(27), 1-164.